SCHEMBL8543721

SCHEMBL8543721

CNC(=O)Oc1cccc(C2CCCN2CCCN2CCOCC2)c1

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.45
EPHX2 P34913 7/20 0.44
HRH3 Q9Y5N1 5/20 0.42
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8546135 0.98 ACHE (0.47) ACHEEPHX2HRH3
SCHEMBL8544785 0.97 ACHE (0.46) ACHEEPHX2HRH3
SCHEMBL8539650 0.95 ACHE (0.46) ACHEEPHX2HRH3CYP2C9CYP2C19
SCHEMBL8544287 0.83 HRH3 (0.45) ACHEHRH3
SCHEMBL8542776 0.82 ACHE (0.58) ACHE
SCHEMBL8539614 0.81 ACHE (0.52) ACHEHRH3
SCHEMBL8544556 0.80 MEN1 (0.43) ACHECYP2C9CYP2C19
SCHEMBL9316755 0.80 OPRM1 (0.52) ACHE
SCHEMBL8539296 0.79 ACHE (0.50) ACHE
SCHEMBL8539445 0.78 THRB (0.53) HRH3CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0671388-B1 (Pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments HOECHST MARION ROUSSEL INC (US) 1998-06-10 EP disclosed
US-5591856-A CHEMICAL INTERMEDIATES, TREATMENT OF ALZHEIMER'S DISEASE HOECHST ROUSSEL PHARMACEUTICALS INC. (US) 1997-01-07 US disclosed
US-5554750-A TO RELIEVE MEMORY DYSFUNCTIONS; TREATMENT OF ALZHEMER*S HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1996-09-10 US disclosed
EP-0671388-A1 (Pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1995-09-13 EP disclosed
US-5405845-A Administering to relieve memory dysfunction; treatment of Alzheimer's disease HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1995-04-11 US disclosed
US-5338739-A Memory dysfunction relieving compounds HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-16 US disclosed